DUBLIN--(BUSINESS WIRE)--Research and Markets (http://www.researchandmarkets.com/research/7v7nn5/u_s_market_for_ur) has announced the addition of the "U.S. Market for Urological Devices (Executive Summary)" report to their offering.
In 2011, the prostate cancer treatment device market was both the largest and fastest-growing segment in the total U.S. market for urological devices. Procedural growth in the market is expected to increase over the 2011-2018 forecast period due to the expected rise in the aging population of the baby boomer generation as well as increases in early diagnosis.
In 2011, the U.S. market for urological devices was valued at $3.5 billion. This report analyzes the markets for the treatment of:
- benign prostate hyperplasia (BPH),
- prostate cancer,
- urinary incontinence as well as
- urinary and kidney stones.
Other markets analyzed include:
- bladder cancer fulguration,
- urodynamic equipment,
- urodynamic equipment and
- nephrostomy devices.
Within the urological device market, companies such as Coloplast, C.R. Bard, Intuitive Surgical, and Varian Medical Systems lead the market, among many others. This report provides a comprehensive and detailed analysis of market revenues by device type, market forecasts through 2018, unit sales, average selling prices, market drivers and limiters and a detailed competitive analysis, including manufacturer market shares and product portfolios.
For more information visit http://www.researchandmarkets.com/research/7v7nn5/u_s_market_for_ur